SCYNEXIS Reports Full Year 2017 Financial Results and Provides Company Update

March 13, 2018

Responsive image

JERSEY CITY, N.J., March 13, 2018 /PRNewswire/ — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today reported financial results for the year ended December 31, 2017, and…

Category: Precious Metals